Eli Lilly neuroscience chief resigns

Quote






Exactly what I said a while back; the failed academic returning to academia--no doubt, UC SanFranSicko. Now, if only the OTHER DB would leave, the NSD group might have a chance...on second thought, it is too far gone.
 






Breakdown

Poor DB. At Jan's last top-to-bottom portfolio review/prioritization meeting, DB, the feckless wonder of NSD, stood there with his 5 O'Clock shadow and stammered like an imbecile. A near four-alarm Charlie Sheen like meltdown as he tried to justify the failures under his watch. The VPs and CSOs just looked around at each other and sent messages on their blackberries. It was quite a scene.
 






Re: Breakdown

Breakdown said:
Poor DB. At Jan's last top-to-bottom portfolio review/prioritization meeting, DB, the feckless wonder of NSD, stood there with his 5 O'Clock shadow and stammered like an imbecile. A near four-alarm Charlie Sheen like meltdown as he tried to justify the failures under his watch. The VPs and CSOs just looked around at each other and sent messages on their blackberries. It was quite a scene.
Click to expand...

So, exactly what happened at the review? Heavy grilling? Fiery responses? High level tension in the room?
 






Re: Breakdown

Anonymous said:
So, exactly what happened at the review? Heavy grilling? Fiery responses? High level tension in the room?
Click to expand...

Yes. Yes. YES! He was dressed down for the lack of the division delivering ANYTHING during his tenure, and the even more staggering lack of anything of value in the early stage NSD portfolio. He's safe now that he's gone but the collateral damage to others will be ugly
 






Re: Breakdown

Anonymous said:
Yes. Yes. YES! He was dressed down for the lack of the division delivering ANYTHING during his tenure, and the even more staggering lack of anything of value in the early stage NSD portfolio. He's safe now that he's gone but the collateral damage to others will be ugly
Click to expand...

Think he'll be replaced by someone internal or external? Also, what caused this long string of failures? Seems like there has been and is a big shakedown in R&D leadership this past year. How about the ONC pipeline and leadership? Other than ONC and Diabetes, what's left to bolster the future?
 


















Re: Breakdown

Anonymous said:
Think he'll be replaced by someone internal or external? Also, what caused this long string of failures? Seems like there has been and is a big shakedown in R&D leadership this past year. How about the ONC pipeline and leadership? Other than ONC and Diabetes, what's left to bolster the future?
Click to expand...

The sad fact is, there is NOBODY internal who could or should fill this role. I'm sure there are plenty who think they should, like the OTHER DB, whose DHT has delivered NOTHING thus far under his tenure. Thing is, who would WANT the position? It's like booking a seat on the Titanic while it's 2/3 submerged. NSD is now DOA. In an ideal world, the resources would be diverted to support the therapeutic areas that can deliver. BUT THERE ARE NONE AT LLY!
 






Re: Breakdown

Anonymous said:
The sad fact is, there is NOBODY internal who could or should fill this role. I'm sure there are plenty who think they should, like the OTHER DB, whose DHT has delivered NOTHING thus far under his tenure. Thing is, who would WANT the position? It's like booking a seat on the Titanic while it's 2/3 submerged. NSD is now DOA. In an ideal world, the resources would be diverted to support the therapeutic areas that can deliver. BUT THERE ARE NONE AT LLY!
Click to expand...

I suggest a high-level six sigma task force to address this issue.

--black belt
 












Re: Breakdown

Anonymous said:
Yes. Yes. YES! He was dressed down for the lack of the division delivering ANYTHING during his tenure, and the even more staggering lack of anything of value in the early stage NSD portfolio. He's safe now that he's gone but the collateral damage to others will be ugly
Click to expand...

These guys get a ton of money in salary, and an overall huge compensation package when they work at that level for us. it's not too bad to see them sweat for awhile in front of management when they haven't delivered. I like the smell of a VP sweating.
 






Re: Breakdown

Anonymous said:
These guys get a ton of money in salary, and an overall huge compensation package when they work at that level for us. it's not too bad to see them sweat for awhile in front of management when they haven't delivered. I like the smell of a VP sweating.
Click to expand...

Is it different from the smell of a lowly associate sweating?
 






Part of the problem was that his age - got a high-level position at age 32 or 33 after a solid reco from Sol Snyder (Nobel Prize for neuroscience). DB may be a too good a guy but certainly not effective in communicating than average lab associates, nor his pointed shoes and high rise collars.

The guy will manage solid NIMH and HHMI grants for sure. One thing he sure learned that discovery science is a whole lot different than implementing a new drug in the midst of a peccary fight. I hope that now MBAs can deliver a good drug.

Lilly has to lose all its NS division now. When will be the Thumbelina and Tàijiàn go, Jan? John? Bring down the house of cards and chicanery for you to be awarded your bonuses and golden parachute?
 












Anonymous said:
What is the general feeling about David Bredt at Lilly? Because from these posts, it seems pretty negative. In general, what is the attitude regarding his tenure there?
Click to expand...

He was a useless Hackademic who delivered nothing but failure during his time here. His departure was unlamented. Good luck J&J--you deserve him!
 






























Top Bottom
Back
Quote